Cancer control collaborations between China and African countries

Area of Science:

• Global Health
• Oncology
• International Relations

Background:

• China is Africa's largest trade partner and investor, prioritizing public health.
• Cancer is a leading cause of death in Africa, with rising mortality rates.
• China-Africa collaborations have significantly increased over the past decade.

Purpose of the Study:

• To explore the effects of China-Africa collaborations on cancer control in Africa.
• To review existing literature and survey African oncology professionals' perceptions.
• To identify challenges and benefits of these partnerships.

Main Methods:

• Systematic review of peer-reviewed articles and grey literature.
• Institutional review board-approved survey of African oncology health-care professionals and leaders.
• Analysis of collaborations in patient care, research, education, training, and infrastructure.

Main Results:

• Substantial growth in China-Africa collaborations, particularly in patient care and infrastructure.
• Increased research publications, but direct research collaborations remain infrequent.
• Survey indicates challenges in monitoring, evaluation, and coordination, alongside benefits like improved health outcomes and strengthened systems.

Conclusions:

• China-Africa collaborations are expanding and significantly impacting both regions.
• Improvements in cancer control are evident, but research collaboration needs enhancement.
• Recommendations focus on minimizing challenges and maximizing benefits for effective cancer control in Africa.